Capital International Sarl Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$18.6M |
| 2 |
Meta Platforms (Facebook)
META
|
+$13.3M |
| 3 |
Broadcom
AVGO
|
+$9.41M |
| 4 |
Tesla
TSLA
|
+$7.57M |
| 5 |
Salesforce
CRM
|
+$7.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$8.99M |
| 2 |
Edwards Lifesciences
EW
|
+$6.3M |
| 3 |
Sempra
SRE
|
+$4.5M |
| 4 |
Corteva
CTVA
|
+$3.85M |
| 5 |
HES
Hess
HES
|
+$3.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.32% |
| 2 | Healthcare | 16.49% |
| 3 | Consumer Discretionary | 13.29% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 10.63% |
Similar funds
Capital International Sarl's Q4 2023 Portfolio in Review
As of Q4 2023, Capital International Sarl held 229 positions worth $2.67B, up 22% from $2.19B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital International Sarl deployed $193M of net new capital in Q4 2023, opening 8 new positions and adding to 140 existing holdings. Its largest new stake was Brookfield: 172,452 shares worth $4.61M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $6.3M trimmed.
- Capital International Sarl's largest Q4 2023 buy was Brookfield: 172,452 shares worth $4.61M.
- Capital International Sarl added most to Microsoft in Q4 2023, an estimated $18.6M increase.
- Capital International Sarl's biggest Q4 2023 reduction was Edwards Lifesciences, cutting an estimated $6.3M.
- Capital International Sarl fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $8.99M.
- Capital International Sarl's ten largest holdings make up 28% of its $2.67B portfolio in Q4 2023.
- Capital International Sarl opened 8 new positions and closed 7 in Q4 2023.
- Capital International Sarl's portfolio value rose 22% quarter-over-quarter to $2.67B.
Based on Capital International Sarl's 13F filing for Q4 2023, filed 13 Feb 2024.